Toini I. Uutela

Rovaniemi, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Journal: Rheumatology international

Published: April 29, 2021

Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study.

Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study.

Journal: The Journal of rheumatology

Published: November 05, 2019

Automated Text Message-Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial.

Automated Text Message-Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial.

Journal: Arthritis care & research

Published: May 25, 2018

Early Targeted Combination Treatment With Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Long-Term Outcomes in Rheumatoid Arthritis: Ten-Year Follow-Up Results of a Randomized Clinical Trial.

Early Targeted Combination Treatment With Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Long-Term Outcomes in Rheumatoid Arthritis: Ten-Year Follow-Up Results of a Randomized Clinical Trial.

Journal: Arthritis care & research

Published: March 13, 2018

Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland.

Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland.

Journal: Scandinavian journal of rheumatology

Published: December 10, 2016

Decreasing muscle performance associated with increasing disease activity in patients with rheumatoid arthritis.

Decreasing muscle performance associated with increasing disease activity in patients with rheumatoid arthritis.

Journal: PloS one

Published: November 06, 2016

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.

Journal: PloS one

Published: October 28, 2016

Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study.

Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study.

Journal: Seminars in arthritis and rheumatism

Published: May 11, 2016

Self-rated health in patients with rheumatoid arthritis is associated with health-related quality of life but not with clinical variables.

Self-rated health in patients with rheumatoid arthritis is associated with health-related quality of life but not with clinical variables.

Journal: Scandinavian journal of rheumatology

Published: January 26, 2016

Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990s.

Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990s.

Journal: Scandinavian journal of rheumatology

Published: December 03, 2014

Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial.

Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial.

Journal: The Journal of rheumatology

Published: October 03, 2014

A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland.

A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland.

Journal: Scandinavian journal of rheumatology

Published: March 25, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026